Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_assertion type Assertion NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_head.
- NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_assertion wasGeneratedBy ECO_0000203 NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_provenance.
- NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_assertion wasDerivedFrom befree-20140225 NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_provenance.
- NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_assertion SIO_000772 21825227 NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_provenance.
- NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_assertion evidence source_evidence_literature NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_provenance.
- NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_assertion description "[Randomized treatment of patients with stable coronary artery disease with the AT(1)-R blocker telmisartan significantly increased the number of circulating CD34/KDR-positive EPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610824.RAw-KBhXxMT71gJfqYSh945kQ0PvKi-l1F_ytXZdeCa3s130_provenance.